Our Mission|Our Team|Investment Criteria|The Review Process

Pollen Ventures has a history of recognizing significant innovations ahead of the majority of investors. This is consistent with our overall philosophy of looking over the technological horizon for opportunities.

Historically, we have invested in biopharamaceuticals, medical devices, drug delivery systems, diagnostics and capital equipment that meets this criteria. As technology advancement has created new opportunities, we have increased our focus in several areas. These include tools for increased drug development efficiencies such as bioinformatics, biochips, and high throughput systems that provide increased knowledge rather than just data.

We also are exploring the synergistic strengths we can provide as investors through the convergence of Information Technology and Life Science practices. This can be in the previously mentioned area of bioinformatics or our new focus on the emerging opportunities in telemedicine.

Due to the backgrounds our partners possess in actual start up management and technical training, we are comfortable investing at the earliest stages of opportunities and believe this is where we can add the most value. Consequently, we are continually visiting academic institutions, research facilities and other such institutions in order that we might stay on the cutting edge of the life sciences.